These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Merits and liabilities of NSAID therapy. Roth SH Rheum Dis Clin North Am; 1989 Aug; 15(3):479-98. PubMed ID: 2672133 [TBL] [Abstract][Full Text] [Related]
3. Non steroidal anti-inflammatory drugs. Day RO Aust Fam Physician; 1987 Jun; 16(6):799, 803, 805 passim. PubMed ID: 3499886 [No Abstract] [Full Text] [Related]
4. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Bertolini A; Ottani A; Sandrini M Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982 [TBL] [Abstract][Full Text] [Related]
5. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77]. Fenn GC; Morant SV Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122 [No Abstract] [Full Text] [Related]
6. Management of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs during the therapy of rheumatic diseases. The rheumatologist's perspective. Robinson DR Am J Med; 1988 Feb; 84(2A):1-4. PubMed ID: 3126654 [TBL] [Abstract][Full Text] [Related]
7. Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data. Fries J Scand J Rheumatol Suppl; 1996; 102():3-8. PubMed ID: 8628980 [TBL] [Abstract][Full Text] [Related]
8. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs. Peura DA; Goldkind L Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079 [TBL] [Abstract][Full Text] [Related]